| Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism I Smaga, E Niedzielska, M Gawlik, A Moniczewski, J Krzek, E Przegaliński, ... Pharmacological Reports 67 (3), 569-580, 2015 | 283 | 2015 |
| Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist E Przegaliński, E Tatarczyńska, A Dereń-Wesołek, E Chojnacka-Wojcik Neuropharmacology 36 (1), 31-37, 1997 | 139 | 1997 |
| GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators M Filip, M Frankowska, A Sadakierska-Chudy, A Suder, Ł Szumiec, ... Neuropharmacology 88, 36-47, 2015 | 116 | 2015 |
| The role of nitric oxide in the kainate-induced seizures in mice E Przegaliński, L Baran, J Siwanowicz Neuroscience letters 170 (1), 74-76, 1994 | 111 | 1994 |
| The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats P Adamczyk, J Miszkiel, AC McCreary, M Filip, M Papp, E Przegaliński Brain research 1444, 45-54, 2012 | 108 | 2012 |
| Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine M Filip, M Frankowska, M Zaniewska, E Przegaliński, CE Műller, L Agnati, ... Brain research 1077 (1), 67-80, 2006 | 107 | 2006 |
| Behavioral evidence for the significance of serotoninergic (5‐HT) receptors in cocaine addiction M Filip, N Alenina, M Bader, E Przegaliński Addiction biology 15 (3), 227-249, 2010 | 104 | 2010 |
| The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression E Przegaliński, E Moryl, M Papp Neuropharmacology 34 (10), 1305-1310, 1995 | 93 | 1995 |
| Clonidine-induced locomotor hyperactivity in rats: the role of central postsynaptic α-adrenoceptors I Żebrowska-Łupina, E Przegaliński, M Słoniec, Z Kleinrok Naunyn-Schmiedeberg's Archives of Pharmacology 297, 227-231, 1977 | 82 | 1977 |
| Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the … A Moniczewski, M Gawlik, I Smaga, E Niedzielska, J Krzek, E Przegaliński, ... Pharmacological Reports 67 (3), 560-568, 2015 | 73 | 2015 |
| Effects of GABAB receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination M Filip, M Frankowska, E Przegaliński European journal of pharmacology 574 (2-3), 148-157, 2007 | 70 | 2007 |
| Ceramide and its related neurochemical networks as targets for some brain disorder therapies J Brodowicz, E Przegaliński, CP Müller, M Filip Neurotoxicity research 33, 474-484, 2018 | 68 | 2018 |
| Involvement of 5-HT1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats E Chojnacka-Wojcik, E Tatarczyńska, K Gołembiowska, E Przegaliński Neuropharmacology 30 (7), 711-717, 1991 | 59 | 1991 |
| Effects of serotonin 5-HT1B receptor ligands on the cocaine-and food-maintained self-administration in rats E Przegaliński, A Gołda, M Frankowska, M Zaniewska, M Filip European journal of pharmacology 559 (2-3), 165-172, 2007 | 58 | 2007 |
| The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(di-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat E Przegaliński, AM Ismaiel, E Chojnacka-Wojcik, B Budziszewska, ... Neuropharmacology 29 (6), 521-526, 1990 | 58 | 1990 |
| Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats E Przegaliński, M Filip, M Frankowska, M Zaniewska, I Papla Neuropeptides 39 (5), 525-533, 2005 | 57 | 2005 |
| Relationship of maternal high-fat diet during pregnancy and lactation to offspring health K Gawlińska, D Gawliński, M Filip, E Przegaliński Nutrition reviews 79 (6), 709-725, 2021 | 55 | 2021 |
| Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat E Przegaliński, B Budziszewska, A Warchoł-Kania, E Błaszczyńska Pharmacology Biochemistry and Behavior 33 (2), 329-334, 1989 | 55 | 1989 |
| Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats M Zaniewska, AC McCreary, E Przegaliński, M Filip European journal of pharmacology 540 (1-3), 96-106, 2006 | 52 | 2006 |
| Effect of adrenalectomy and corticosterone on cocaine-induced sensitization in rats E Przegalinski, M Filip, J Siwanowicz, E Nowak Journal of Physiology and Pharmacology 51 (2), 2000 | 51 | 2000 |
